Optiver Holding
AXSM icon

Optiver Holding’s Axsome Therapeutics AXSM Stock Holding History

Optiver Holding’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-69
Closed -$11.7K – 2787
2026
Q1 		$11.7K Sell
69
-43
-38% -$7.43K ﹤0.01% 1193
2025
Q4 		$20.5K Sell
112
-176
-61% -$24.6K ﹤0.01% 1023
2025
Q3 		$35K Buy
288
+130
+82% +$14.6K ﹤0.01% 849
2025
Q2 		$16.5K Buy
158
+98
+163% +$10.4K ﹤0.01% 884
2025
Q1 		$7K Buy
+60
New +$6.84K ﹤0.01% 1003

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Optiver Holding's AXSM Position: Q2 2026 in Review

Optiver Holding sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 69 shares — an estimated $11.7K sold.

Optiver Holding first reported a position in AXSM in Q1 2025 and held it in 5 quarters. The position peaked at $35K in Q3 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Optiver Holding reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 69 Axsome Therapeutics shares in Q2 2026, an estimated $11.7K.
  • Optiver Holding first reported a position in Axsome Therapeutics in Q1 2025 and held it in 5 quarters.
  • Optiver Holding's Axsome Therapeutics position peaked at $35K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.